As of November 6, 2026, Guardant Health, Inc. is a publicly traded company (Nasdaq: GH); its largest reported holder is Fidelity (FMR), with 5.8% on Schedule 13G of November 5, 2026, then BlackRock (5.2%) (Schedule 13G, November 5, 2026).
Is this your company?
About to sign with, pay or invest in Guardant Health, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Guardant Health, Inc. a real, registered company?
- Guardant Health, Inc. files with the SEC under CIK 1576280 (its SEC filings).
- Its shares are listed under the ticker GH on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Palo Alto, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GUARDANT HEALTH INC in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Kevin R. Sayer, Director (Form 8-K filed 2026-11-03). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Guardant Health, Inc.'s owners and officers?
Guardant Health, Inc.: incorporated in Delaware; business address in Palo Alto, California; industry Services-Medical Laboratories (Schedule 13G, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-11-05 | Fmr LLC | 5.8% |
| Schedule 13G/A, 2026-08-14 | T. Rowe Price Associates, Inc. | 4.9% |
| Schedule 13G/A, 2026-07-28 | Blackrock, Inc. | 5.2% |
| Schedule 13G, 2026-05-15 | T. Rowe Price Associates, Inc. | 5.4% |
| Schedule 13G, 2026-04-30 | Vanguard Capital Management | 5.02% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
Questions about who owns Guardant Health, Inc.
Who owns Guardant Health, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Guardant Health, Inc.: Fmr LLC (5.8%, Schedule 13G, filed 2026-11-05), Blackrock, Inc. (5.2%, Schedule 13G/A, filed 2026-07-28) and Vanguard Capital Management (5.02%, Schedule 13G, filed 2026-04-30).
Who are the largest shareholders of Guardant Health, Inc.?
By the share each holder's latest filing reports, the largest holders of Guardant Health, Inc. on this page are Fmr LLC (5.8%), Blackrock, Inc. (5.2%) and Vanguard Capital Management (5.02%).
When did Fmr LLC buy into Guardant Health, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G, filed 2026-11-05, reporting 5.8%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Guardant Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Guardant Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Guardant Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-11-03 | Kevin R. Sayer | Director | appointed | 2026-11-02 |
| Form 8-K, 2026-11-03 | Robert A. Parks | Chief Accounting Officer | appointed |
Which insiders own Guardant Health, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 1,958,949 shares (1.4% of shares outstanding), held indirectly through a shares held by helmy a. eltoukhy revocable trust (Form 4, 2026-10-02).
- , the chief executive and a director: 1,842,366 shares (1.4% of shares outstanding), held indirectly through a shares held by talasaz and eskandari 2017 family trust (Form 4, 2026-10-02).
- , the chief technology officer: 74,348 shares (0.05% of shares outstanding) (Form 4, 2026-10-02).
- , the chief medical officer: 72,001 shares (0.05% of shares outstanding) (Form 4, 2026-04-02).
- , the chief commercial officer: 69,647 shares (0.05% of shares outstanding) (Form 4, 2026-10-02).
Shares outstanding: 135,285,975 as of 2026-10-30, from the company's latest SEC cover page.
How much has Guardant Health, Inc. raised?
No fundraising or offering filing from Guardant Health, Inc. is on file with us.
Keep reading
More on Guardant Health, Inc. and the records around it.
Guardant Health, Inc. elsewhere on the record
- Leadership changes Apr 2026
Companies that share a holder
- T. Rowe Price Associates, Inc. also filed stake reports on 191 other companies: PACIFIC BIOSCIENCES OF CALIF (Nov 2026), APARTMENT INVT & MGMT CO -A (Oct 2026), BETA BIONICS INC (Oct 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/guardant-health